PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification
Background. There is a patent need to better characterize early-stage colorectal cancer (CRC) patients. PD-1 ligand (PD-L1) expression has been proposed as a prognostic factor but yields mixed results in different settings. The Consensus Molecular Subtype (CMS) classification has yet to be integrate...
Main Authors: | Pablo Azcue, Ignacio Encío, David Guerrero Setas, Javier Suarez Alecha, Arkaitz Galbete, María Mercado, Ruth Vera, Maria Luisa Gomez-Dorronsoro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/8/1943 |
Similar Items
-
Circular RNA in Chemonaive Lymph Node Negative Colon Cancer Patients
by: Inge van den Berg, et al.
Published: (2021-04-01) -
PD-1-siRNA Delivered by Attenuated Salmonella Enhances the Antitumor Effect of Chloroquine in Colon Cancer
by: Shuya Lu, et al.
Published: (2021-07-01) -
Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision
by: Rebersek Martina
Published: (2020-05-01) -
Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells
by: Deepa Bedi, et al.
Published: (2019-04-01) -
ZG16 regulates PD-L1 expression and promotes local immunity in colon cancer
by: Hui Meng, et al.
Published: (2021-02-01)